REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – A new study ...
REPORTING FROM ACTRIMS FORUM 2018 San Diego (FRONTLINE MEDICAL NEWS) – Compared with controls, ...
REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Multiple sclerosis (MS) ...
FROM EPILEPSIA A substantial portion of older adults with epilepsy who are on Medicare ...
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – A postmarketing study of ...
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – The benefits of mechanical ...
REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Multiple sclerosis appears ...
Another one bites the dust. Yet another investigational agent joins intepirdine, verubecestat, solanezumab, bapineuzumab, ...
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – In patients who had ...
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – Thrombolysis with tenecteplase beat ...
FROM ACTRIMS FORUM 2018 Researchers are heading back to the drawing board after a ...
FROM ACTRIMS FORUM 2018 Pediatric patients with relapsing remitting multiple sclerosis (MS) had fewer ...
FROM ACTRIMS FORUM 2018 Newer disease-modifying therapies are often used in patients with pediatric-onset ...